KALA BIO, Inc. (KALA)
Last updated: 2026-10-24 17:40:40. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
KALA BIO, Inc. (KALA) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.19, with a market capitalization of $3.59M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.11 to $95.50. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$3.59M | |
$0.19 | |
$66,808.19 | |
$0.11 | |
$0.19 | |
3.10K | |
1.53M | |
-- | |
$95.50 | |
$0.11 | |
-- | |
-- |
KALA BIO, Inc. (KALA) Latest Closing Stock Price
KALA BIO, Inc. (KALA) last closed at $0.19 as of 2026-10-23 23:31:00, unchanged from the previous close of $0.19.
During the latest regular trading session, KALA traded between $0.11 and $66,808.19, with a volume of 3.10K shares. The closing price was near the lower end and near the lower end of its 52-week range.
KALA BIO, Inc. (KALA) 7-Day Stock Price Change
Over the past seven days, KALA BIO, Inc. (KALA) moved from $0.19 to $0.19, representing a decline of 1.14% ($0.00).
The stock traded between $0.17 and $0.21 during the period. The latest price is near the middle of the 7-day range, indicating moderate downward.
The average daily volume was 334.56 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
KALA 52-Week Price Position
Position in Range: 0.1%
KALA is currently trading at $0.19, placing it 0.1% of the way from its 52-week low of $0.11 to its 52-week high of $95.50. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is KALA BIO, Inc. (KALA)?
Kala Bio Inc is a clinical-stage biopharmaceutical company dedicated to the research, development and commercialization of inventive therapies for rare and severe diseases of the front and back of the eye. It main product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
KALA BIO, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 6 |
| Exchange | NASDAQ |
| Company Website |
How to Buy KALA BIO, Inc. (KALA) Stock on MEXC
Eligible investors can buy real shares of KALA BIO, Inc. (KALA) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is KALA BIO, Inc. (KALA) stock price today?
2.Is KALA stock going up or down today?
3.What is KALA pre-market price?
4.What is KALA after-hours price?
5.Is KALA stock trading now?
6.Where does KALA sit relative to its 52-week high and low?
7.What sector is KALA BIO, Inc. in?
8.What is KALA BIO, Inc.'s market capitalization and where is it listed?
9.How is KALA valued in terms of P/E ratio and EPS?
10.Does KALA BIO, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
KALA Stock Calculator
Estimate the value between KALA shares and USD.
KALA Shares to USD
1.00 KALA shares = 0.19 USD
Calculations are estimates based on the latest available price and are for reference only.


